Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12
Get Alerts DPLO Hot Sheet
Join SI Premium – FREE
FLINT, Mich., Oct. 30, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will release its third-quarter 2019 operating results before market open Tuesday, Nov. 12. A conference call and live webcast will be held at 8:30 a.m. ET.

Shareholders and interested participants can listen to a live broadcast by calling 833.286.5805 (647.689.4450 for international callers) and entering participation code 4382088, about 15 minutes before the call. A live webcast of the conference call will be available on the investor relations section of Diplomat's website at ir.diplomat.is. The site will host an audio recording and supplemental investor information for 90 days.
About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient-care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.
CONTACT:Terri Anne Powers, Vice President of Investor Relations312.889.5244 | [email protected]
Jennifer Pavlovich, Corporate Communications Manager810.768.9282 | [email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-to-release-third-quarter-2019-operating-results-nov-12-300948569.html
SOURCE Diplomat Pharmacy, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
- David Ferrera Announces New Neurovascular and Medical Device Manufacturing Ventures in the Middle East and Africa
- SystImmune, Inc. to Present New Global Data on Iza-bren (izalontamab brengitecan) in EGFR-mutated Non-Small Cell Lung Cancer at WCLC Congress 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share